time to onset.(5) Japanese Adverse Drug Reaction Reporting Database(5) Hepatocellular carcinoma(5) skin damage(5) Bendamustine(5) Breast cancer(3) review(2) COVID-19(2) sorafenib(2) Hepatitis B virus(2) unresectable.(1) survival(1) Prognosis(1) integration(1) COVID-19 strategies(1) Chemotherapy(1) food fortification(1) HBV(1) fibroblast growth factor receptor(1) conversion(1) host immunity(1) head and neck cancer(1) HCC(1) hematogenous metastasis(1) Thromboprophylaxis(1) human ESPL1.(1) Supplementation(1) outcome(1) Single nucleotide polymorphism(1) HBV-DNA(1)